Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in Restless Legs Syndrome
NCT01192503Phase 3Terminated
- Sponsor
- University of Virginia
- Start
- Sep 2010
- Primary completion
- Jun 2012
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in restless legs syndrome (RLS), sponsored by University of Virginia. Started Sep 2010; status: terminated.
02
Drugs
rasagiline
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01192503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192503.